The Portuguese generic medicines market: What's next?

Health Policy
Alexandre Morais NunesRui Miranda Julião

Abstract

Brand-name medicines have dominated the Portuguese market for several decades with unquestionable exclusivity. This resulted particularly from the absence of a requirement of prescriptions by international non-proprietary name. To promote the enhancement of both efficiency and sustainability in the health system, the Portuguese government introduced the generics in Portugal by the 90 s. However, only in the first decade of the 21st century were some policies implemented to increase their market share. Although some expectations were created, the use of generics has increased moderately during that period, in which policies to promote them were consolidated by imposing the austerity principles in the midst of the economic and social crisis. This study analyses the main policy measures already implemented as well as the incentives created for the replacement of brand-name medicines with generics. In addition, the present study also makes some recommendations to promote a broader and better use of generics in Portugal.

References

Oct 16, 2004·The New England Journal of Medicine·Paul B Ginsburg
Jun 18, 2005·Epilepsy & Behavior : E&B·Lisa S HaskinsPamela Crawford
Jul 19, 2008·Health Economics, Policy, and Law·Todd H WagnerJohn D Piette
Jun 19, 2010·Pharmacy World & Science : PWS·Zaheer-Ud-Din BabarAnne Rew
Sep 16, 2011·Journal of Health Economics·Roger BateAparna Mathur
May 11, 2012·Health Policy·Pedro Pita Barros
Apr 2, 2013·Lancet·Marina KaranikolosMartin McKee
Sep 10, 2014·European Journal of Internal Medicine·Giovanni CorraoAlberico L Catapano
Feb 24, 2015·Social Science & Medicine·Niels Skipper, Rune Vejlin
Jun 23, 2015·American Journal of Therapeutics·Robert J StrakaLarry Z Liu
Sep 21, 2015·Epilepsy & Behavior : E&B·Joshua J GagneWilliam H Shrank
Oct 20, 2015·Health Policy·Leonora N Skaltsas, Konstantinos Z Vasileiou
Jul 13, 2016·Mayo Clinic Proceedings·Maria Elena FlaccoJohn P A Ioannidis
Feb 25, 2017·Health Policy·Cristina ZerbiniDonata Tania Vergura
Sep 13, 2017·The Milbank Quarterly·Olivier J WoutersMartin McKEE
Jan 10, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sonal Singh
Aug 16, 2018·The International Journal of Health Planning and Management·Alexandre Morais Nunes, Diogo Cunha Ferreira
Feb 13, 2019·Research in Social & Administrative Pharmacy : RSAP·Natalie S HohmannJingjing Qian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of the Indiana State Medical Association
V E Tyler
Fundamental & Clinical Pharmacology
Claire Le Jeunne
Journal of Drugs in Dermatology : JDD
Leon H Kircik
© 2021 Meta ULC. All rights reserved